What We're Reading: Page 141
Industry reads hand-picked by our editors
Aug 25, 2021
-
MIT Technology Review
Is Ginkgo’s synthetic-biology story worth $15 billion?
-
The Atlantic
The FDA Really Did Have to Take This Long
-
The Boston Globe
Moderna is now the third largest biotech employer based in Mass.
-
Endpoints News
Roche tees up $3B+ for Shape's RNA editing platform, with the bold promise of 'one-time' cures for Alzheimer's, Parkinson's
Aug 24, 2021
-
STAT
Flagship, Orbimed, ARCH top list of high-performing biotech VC firms
-
Bloomberg
Small-Cap Biotech Stocks Play Catch Up With Industry Leaders
-
Endpoints News
PDUFA VII: What's new, and what's significant in the next user fee deal
-
Fierce Biotech
Merck KGaA's $4.2B bintrafusp alfa nabs a 3rd strike. Is the GSK-partnered cancer hopeful out?
Aug 23, 2021
-
Business Insider
MIT's David Sabatini on Leave Following Sexual Harassment Investigation
-
Higher Ed Dive
Would full FDA approval of coronavirus vaccines alter colleges' fall plans?
-
The New York Times
Maker of Rapid Covid Tests Told Factory to Destroy Inventory
-
POLITICO
White House to House Dems: Drug price plan is a winning issue
Aug 20, 2021
-
Science
New SARS-CoV-2 variants have changed the pandemic. What will the virus do next?
-
Reuters
Richard Sackler says Purdue family did not contribute to opioid epidemic
-
The Washington Post
U.S. officials reviewing possibility Moderna vaccine is linked to higher risk of uncommon side effect than previously thought
Aug 19, 2021
-
STAT
‘Remember her as the badass she was’: ALS patient who died should force Biogen, others to anticipate expanded access issues
-
The Wall Street Journal
As Covid-19 Boosters Loom, Pfizer and Moderna Expected to See Billions More in Sales
-
Science
COVID-19 vaccines may trigger superimmunity in people who had SARS long ago
-
Reuters
China's mRNA vaccine technology firm Abogen raises over $700 million
Aug 18, 2021
-
Forbes
Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible
-
STAT
Sesen Bio drug trial marked by misconduct, other issues, documents show
-
The New York Times
Sacklers Threaten to Pull Out of Opioid Settlement Without Broad Legal Immunity
-
FiercePharma
5 years after Pfizer buyout, SEC charges Medivation's former deal-making lead with insider trading
Aug 17, 2021
-
Bloomberg
Antibody Cocktails Take Off as Delta Surges
-
The New York Times
This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous
-
Associated Press
Rich nations dip into COVAX supply while poor wait for shots
-
Endpoints News
Dueling 7-figure ad campaigns set sights on a big drug price negotiation bill coming soon
Previous
